tiprankstipranks
Kiniksa Pharmaceuticals (KNSA)
NASDAQ:KNSA
US Market
KNSA
Kiniksa Pharmaceuticals
RESEARCH TOOLSreports

Kiniksa Pharmaceuticals (KNSA) Balance Sheet

555 Followers

Kiniksa Pharmaceuticals Balance Sheet

Kiniksa Pharmaceuticals's total assets for Q4 2025 were $763.63M, an increase of 7.20% from the previous quarter. KNSA total liabilities were $196.03M for the fiscal quarter, a 10.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 763.63M$ 580.55M$ 526.32M$ 459.67M$ 232.80M
Total Liabilities
$ 196.03M$ 142.12M$ 87.48M$ 63.52M$ 47.76M
Total Equity Gross Minority
$ 567.61M$ 438.44M$ 438.84M$ 396.15M$ 185.04M
Other Metrics
Currency in USD

Kiniksa Pharmaceuticals Debt to Assets